fenben lab fenbendazol is an antiparasitic drug that has broad anthelmintic activity in various animals. It is also reported to have antitumor effects in preclinical studies, due to its ability to inhibit cellular growth by binding to b-tubulin microtubules and disrupting their polymerization. However, its safety and tolerability in humans has not been established.
The case of a woman who self-administered fenbendazole and experienced complete remission of her nonsmall cell lung cancer (NSCLC) has prompted questions about the safety of this compound in human patients. The patient received conventional cancer treatments during the time that she took fenbendazole, making it difficult to attribute her remission solely to fenbendazole. Furthermore, her remission might have been the result of other factors such as a change in tumor biology.
NSCLC is a common and fatal disease in which cancer cells proliferate uncontrollably and form a mass within the chest cavity. In order for cells to divide and grow, they need a structure called the mitotic spindle, which is made of microtubules. Microtubules help to align chromosomes in metaphase and then separate them equally during anaphase. Drugs that interfere with the formation of the mitotic spindle inhibit cell division and halt cell growth. Examples of such drugs include paclitaxel, carmustine, and doxorubicin, which are used in chemotherapy for NSCLC patients.
Despite the development of more effective chemotherapeutic agents, NSCLC is still a leading cause of cancer-related mortality worldwide. As a result, many patients are still searching for alternative therapies that may improve their outcomes. The Internet has provided a wealth of information about the use of natural products in the treatment of cancer, including fenbendazole. However, not all online information is reliable. Some websites may contain false or misleading information about the use of fenbendazole in the treatment of NSCLC.
Although fenbendazole is an FDA-approved antiparasitic drug, it is not widely available in the United States. In addition, it has a number of side effects, including nausea and diarrhea. The FDA warns consumers to contact a healthcare professional if they develop any of these symptoms.
Aspirin has a similar effect on microtubules and is more commonly prescribed by doctors than fenbendazole. Its potential for causing serious side effects, including bleeding and hemorrhage, makes it important to discuss any aspirin regimen with your doctor.
The benzimidazole anthelmintic fenbendazole is a broad-spectrum drug with anthelmintic activity in dogs and pigs. It is also reported to have antitumor and antineoplastic properties due to its ability to bind to the b-tubulin subunits of microtubules and inhibit their polymerization. In order to determine the safety and tolerability of fenbendazole in human beings, it is necessary to perform clinical trials with large numbers of patients.